RadNet Reports AI Tool Could Reduce Unnecessary Prostate Biopsies by Nearly 20%
Prostate biopsies are invasive procedures that carry risks including infection, bleeding, and discomfort. RadNet's AI solution analyzes imaging data to help physicians better assess which patients genuinely need a biopsy versus those who may safely avoid the procedure.
The company reports that the AI tool could spare nearly 20% of patients from undergoing unnecessary biopsies. This aligns with broader efforts in radiology to use AI for reducing over-diagnosis and over-treatment, particularly in cancer screening contexts where distinguishing between aggressive and indolent conditions remains challenging.
If validated through broader clinical deployment, such tools could significantly reduce healthcare costs and patient morbidity while maintaining or improving detection rates for clinically significant prostate cancer.